Big Pharma-backed startup to go public by merging with gutted Homology

A three-year-old biotech backed by the venture arms of Sanofi ADR and Bristol Myers Squibb is going public by merging with the embattled Homology Medicines Inc.

Previous FDA classifies Fresenius syringe recall as 'most serious'
Next Drebes: Red states are protecting abortion. But it may not help Missouri Democrats.